Hot Natural Products & Bioactive Compounds

BioCrick offers high-purity natural products and bioactive compounds for scientific research. Our natural product collection includes compounds derived from plants, microorganisms and other biological sources and is widely used in pharmacological, biochemical and drug discovery research.

Natural products remain an important source of bioactive molecules and drug leads. BioCrick provides researchers with high-quality natural product compounds together with catalog numbers, product information and biological activity data.

Hot Products from BioCrick

Showing 9049 - 9056 of 9359 hot products

BioCrick hot natural products and bioactive compounds
Catalog No. Product Name
BCN8172 Protostemonine
1. Protostemonine has anti-inflammatory activity, it effectively attenuates LPS-induced inflammatory responses in vitro and in vivo; the beneficial effects are associated with the decreased phosphorylation of MAPK and AKT and the reduced expression of pro-inflammatory mediators, such as iNOS, NO and cytokines.
2. Protostemonine shows strong nematicidal activity against Panagrellus redivevus, with the IC50 value of 0.10 uM.
3. Protostemonine attenuates LPS/GalN-induced acute liver failure and upregulating HO-1 expression is implicated in its hepatoprotective activity.
4. Protostemonine shows significant antitussive activity in a citric acid-induced guinea pig cough model following peripheral administration.
BCN8173 13-Oxo-9E,11E-octadecadienoic acid
13-Oxo-9E,11E-octadecadienoic acid has antitumor activity.
BCN8174 Neocnidilide
1. Neocnidilide has insecticidal activity, it exhibits LC50 values of 9.90 micromol/mL of diet concentration against larvae of D. melanogaster.
2. Neocnidilide can enhance the skin penetration of benzoic acid.
3. Neocnidilide has antifungal activity.
BCN8175 5'-IMPdisodium salt
1. Used in enzyme analysis; flavour enhancer.
BCN8176 Nornicotine
1. Nornicotine serves as the direct precursor in the synthesis of N'-nitrosonornicotine, a potent carcinogen in laboratory animals.
2. Nornicotine and nicotine each produced a dose-dependent decrease in nicotine self-administration, nornicotine may be an effective treatment for tobacco dependence.
3. Nornicotine inhibits striatal dopamine transporter (DAT) function via a nicotinic receptor (nAChR) -mediated mechanism.
4. S(-)-Nornicotine may be of value, either alone or in combination with an opioid, for treatment of a broad-spectrum of pain (i.e. nociceptive, neuropathic, and mixed pain).
5. Nornicotine and nicotine can promote endothelial cellular proliferation, migration and tube formation of HUVECs in vitro.
BCN8177 Methyl protogracillin
1. Methyl protoneogracillin can cause morphological abnormality of Pyricularia oryzae mycelia.
2. Methyl protoneogracillin shows cytotoxic activitiy against the cancer cell line of K562 in vitro as antineoplastic agents.
BCN8178 Saikosaponin B3
1. Saikosaponin B3 shows some analgesic effect.
BCN8179 Sulforaphene
1. Sulforaphene has herbicidal activity, the ED50 of it against velvetleaf seedlings was approximately 2×10(-4) M.
2. Sulforaphene may be a potential anti- triple negative breast cancer natural compound and its antiproliferation effects may be mediated by tumor suppressor Egr1.
3. Sulforaphene has chemotherapeutic potential, it promotes Bax/Bcl2, MAPK-dependent human gastric cancer AGS cells apoptosis and inhibits migration via EGFR, p-ERK1/2 down-regulation.
4. Sulforaphene enhances radiosensitivity of hepatocellular carcinoma through suppression of the NF-κB pathway.
5. Sulforaphene has anti-proliferative and antibacterial properties.